Patent Evaluation: Hexahydrobenzo[f]quinolines as 5α-Reductase Inhibitors

    June 1993 in “ Current opinion in therapeutic patents ”
    Studysummary This study reports that novel hexahydrobenzoquinolin compounds fully inhibited 5α-reductase activity in human genital skin fibroblasts, suggesting their potential for treating conditions like benign prostatic hyperplasia and male pattern baldness.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on tandfonline.com →
    Discuss this study in the Community →

    Related research 4

    1. Preparation and Clinical Evaluation of Finasteride Gel in the Treatment of Idiopathic Hirsutism Journal of drug assessment · 2015
    2. Relative Safety and Efficacy of Finasteride for Treatment of Hirsutism Annals of Pharmacotherapy · 2004
    3. The Benefits of Finasteride for Hirsute Women with Polycystic Ovary Syndrome or Idiopathic Hirsutism Gynecological Endocrinology · 2003
    4. Finasteride in the Treatment of Hirsutism Journal of women's health · 1995